Our study of 80 retrospectively collected TET including 33 thymic carcinomas and 7 TNETs revealed expression of SSTR2 in all thymic small cell carcinomas, lymphoepithelial carcinomas, and the single adenosquamous carcinoma, three-fourths of thymic squamous cell carcinomas, and 40% of atypical carcinoid tumors. Here, SSTR2 is linked to thymus squamous cell carcinoma.